Dyslipidemia as Predictor of Missed Miscarriage
-
Published:2021-12-10
Issue:4
Volume:11
Page:418-421
-
ISSN:2158-0510
-
Container-title:International Journal of Biomedicine
-
language:
-
Short-container-title:IJBM
Author:
Orazmuradov Agamurad,Morozov Sergey,Akhmatova Anastasiya,Haddad Khalid,Lopatin Alexander,Ramazanova Fatima,Bekbaeva Irina,Kyrtikov Sergey,Suleymanova Zhasmina,Lukaev Aleksey
Abstract
Background: This study aimed at finding the diagnostic and prognostic possibilities of determining apoC-II, as a serological marker for MM in early gestation. Methods and Results: The study included 182 pregnant women aged between 18 and 45 years at gestational age under 11 weeks. All women were divided into 3 groups. Group 1 (Gr1) included 90 women with MM; Group 2 (Gr2) included 52 women with spontaneous miscarriage; Group 3 included 40 women without pathology (control group [CG]). Lipid metabolism disorders were diagnosed according to the Russian national recommendations of the VII revision(the Russian Society of Cardiologists [RSC, 2020]), considering the European recommendations (2019). Proteomic analysis of the blood serum was performed using LC-MS. Abnormalities in the lipid profile were more common in patients with MM and spontaneous abortions: 62.2% and 59.7% of cases, respectively, which correlates with the identified marker apoC-II in Gr1 and Gr2. Conclusion: ApoC-II can be considered as the most promising serologic marker for MM in the early gestation period for women with dyslipidemia.
Publisher
International Medical Research and Development Corporation
Subject
General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Neuroscience